Zepbound and Nausea: What Users Say (Page 4)
Reviews for Zepbound
- San...
- Taken for 1 to 6 months
- July 2, 2024
For Weight Loss (Obesity/Overweight) "Had just a little nausea. Love the ease of the shot. Weight loss is great."
- Ano...
- Taken for less than 1 month
- May 14, 2025
For Weight Loss (Obesity/Overweight) "I have lost 14 lbs in 4 weeks. Extreme fatigue and a little nausea. A little shortness of breath when walking. Feeling weak."
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Contrave
Contrave is an anorexiant and is used to help manage weight in obese or overweight adults with ...
Saxenda
Saxenda (liraglutide) injection is used for weight loss in obese or overweight patients. Includes ...
Provigil
Provigil promotes wakefulness and is used to treat excessive daytime sleepiness caused by ...
Qsymia
Qsymia (phentermine and topiramate) is used together with diet and exercise to treat obesity ...
Frequently asked questions
- Zepbound Vs Mounjaro: Complete Comparison Guide for Weight Loss and Diabetes Treatment
- Ozempic Side Effects to Watch For
- Why am I not losing weight on Mounjaro?
- How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss?
Are you taking this medicine?
Your review helps others make informed decisions.More about Zepbound (tirzepatide)
- Zepbound consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (325)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
For Weight Loss (Obesity/Overweight) "Having great success with weight loss but having trouble with nausea and vomiting."